Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–96.
Article PubMed PubMed Central Google Scholar
Ahmed N, Kadife E, Raza A, Short M, Jubinsky PT, Kannourakis G. Ovarian cancer, cancer stem cells and current treatment strategies: a potential role of magmas in the current treatment methods. Cells. 2020;9(3):719.
Article CAS PubMed PubMed Central Google Scholar
Kossai M, Leary A, Scoazec JY, Genestie C. Ovarian cancer: a heterogeneous disease. Pathobiology. 2018;85(1–2):41–9.
Shimizu A, Sawada K, Kimura T. Pathophysiological role and potential therapeutic exploitation of exosomes in ovarian cancer. Cells. 2020;9(4):814.
Article CAS PubMed PubMed Central Google Scholar
Nakamura K, Sawada K, Kobayashi M, et al. Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target. Cancers (Basel). 2019;11(8):1147.
Article CAS PubMed PubMed Central Google Scholar
Feng W, Dean DC, Hornicek FJ, Shi H, Duan Z. Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol Cancer. 2019;18(1):124.
Article PubMed PubMed Central Google Scholar
Li C, Teixeira AF, Zhu HJ, Ten Dijke P. Cancer associated-fibroblast-derived exosomes in cancer progression. Mol Cancer. 2021;20(1):154.
Article PubMed PubMed Central Google Scholar
Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.
Article CAS PubMed PubMed Central Google Scholar
Han Q, Tan S, Gong L, et al. Omental cancer-associated fibroblast-derived exosomes with low microRNA-29c-3p promote ovarian cancer peritoneal metastasis. Cancer Sci. 2023;114(5):1929–42.
Article CAS PubMed PubMed Central Google Scholar
Chen B, Sang Y, Song X, et al. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics. 2021;11(8):3932–47.
Article CAS PubMed PubMed Central Google Scholar
Li YY, Tao YW, Gao S, et al. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p. EBioMedicine. 2018;36:209–20.
Article PubMed PubMed Central Google Scholar
Zhang H, Deng T, Liu R, et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol Cancer. 2020;19(1):43.
Article CAS PubMed PubMed Central Google Scholar
Chen X, Ren X, Jiaoting E, Zhou Y, Bian R. Exosome-transmitted circIFNGR2 Modulates Ovarian Cancer Metastasis via miR-378/ST5 Axis. Mol Cell Biol. 2023;43(1):22–42.
Article CAS PubMed PubMed Central Google Scholar
Morgan R, Plowright L, Harrington KJ, Michael A, Pandha HS. Targeting HOX and PBX transcription factors in ovarian cancer. BMC Cancer. 2010;10:89.
Article PubMed PubMed Central Google Scholar
Tan X, Liu Z, Wang Y, et al. miR-138-5p-mediated HOXD11 promotes cell invasion and metastasis by activating the FN1/MMP2/MMP9 pathway and predicts poor prognosis in penile squamous cell carcinoma. Cell Death Dis. 2022;13(9):816.
Article CAS PubMed PubMed Central Google Scholar
Kumra H, Reinhardt DP. Fibronectin-targeted drug delivery in cancer. Adv Drug Deliv Rev. 2016;97:101–10.
Article CAS PubMed Google Scholar
Thongchot S, Jamjuntra P, Therasakvichya S, et al. Interleukin-8 released by cancer-associated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells. Int J Oncol. 2021;58(5):14.
Article CAS PubMed PubMed Central Google Scholar
Huang H, Chen AY, Rojanasakul Y, Ye X, Rankin GO, Chen YC. Dietary compounds galangin and myricetin suppress ovarian cancer cell angiogenesis. J Funct Foods. 2015;15:464–75.
Article CAS PubMed PubMed Central Google Scholar
Shimizu A, Sawada K, Kobayashi M, et al. Patient-derived exosomes as siRNA carriers in ovarian cancer treatment. Cancers (Basel). 2024;16(8):1482.
Article CAS PubMed PubMed Central Google Scholar
Deng Y, Tan Y, Zhou D, et al. Single-cell RNA-Sequencing atlas reveals the tumor microenvironment of metastatic high-grade serous ovarian carcinoma. Front Immunol. 2022;13:923194.
Article CAS PubMed PubMed Central Google Scholar
Zhang M, Chen Z, Wang Y, Zhao H, Du Y. The Role of Cancer-Associated Fibroblasts in Ovarian Cancer. Cancers (Basel). 2022;14(11):2637.
Article PubMed PubMed Central Google Scholar
Lim D, Do Y, Kwon BS, et al. Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer. BMB Rep. 2020;53(6):291–8.
Article CAS PubMed PubMed Central Google Scholar
Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18(12):792–804.
Article CAS PubMed PubMed Central Google Scholar
Liu J, Ren L, Li S, et al. The biology, function, and applications of exosomes in cancer. Acta Pharm Sin B. 2021;11(9):2783–97.
Article CAS PubMed PubMed Central Google Scholar
Nameki R, Chang H, Reddy J, Corona RI, Lawrenson K. Transcription factors in epithelial ovarian cancer: histotype-specific drivers and novel therapeutic targets. Pharmacol Ther. 2021;220:107722.
Article CAS PubMed Google Scholar
Padam KSR, Morgan R, Hunter K, Chakrabarty S, Kumar NAN, Radhakrishnan R. Identification of HOX signatures contributing to oral cancer phenotype. Sci Rep. 2022;12(1):10123.
Article CAS PubMed PubMed Central Google Scholar
Wang J, Liu Z, Zhang C, et al. Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients. PeerJ. 2021;9:e10820.
Article PubMed PubMed Central Google Scholar
Xiong R, Long Q, Zhang X, et al. HOXD11 upregulates JAM-A and exerts oncogenic properties via NF-kappaB signaling pathway in esophageal squamous cell carcinoma. Hum Cell. 2023;36(1):244–57.
Article CAS PubMed Google Scholar
Purushothaman A, Bandari SK, Liu J, Mobley JA, Brown EE, Sanderson RD. Fibronectin on the Surface of Myeloma Cell-derived Exosomes Mediates Exosome-Cell Interactions. J Biol Chem. 2016;291(4):1652–63.
留言 (0)